BIOA vs AMPH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

BIOA

48.8
AI Score
VS
BIOA Wins

AMPH

33.6
AI Score

Investment Advisor Scores

BIOA

49score
Recommendation
HOLD

AMPH

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BIOA AMPH Winner
Revenue 5.22M 355.07M AMPH
Net Income -48.35M 36.77M AMPH
Net Margin -925.7% 10.4% AMPH
Operating Income -54.71M 53.36M AMPH
ROE -12.9% 4.8% AMPH
ROA -12.2% 2.1% AMPH
Total Assets 396.93M 1.74B AMPH
Cash 73.96M 223.61M AMPH
Current Ratio 17.19 2.40 BIOA
Free Cash Flow -43.66M 81.07M AMPH

Relative Price Performance (Last 90 Days)

BIOA 1M: -19.0% · 3M: -48.4% AMPH 1M: +19.0% · 3M: +15.8%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -21.1%), weak momentum, RSI 30

RSI (14): 29.5 · Price: $8.49

AMPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.0% over 20 days), RSI 69

RSI (14): 69.3 · Price: $23.78

Fundamentals Snapshot

Metric BIOA AMPH
Market Cap
Forward P/E -3.5 9.0
Trailing P/E 13.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin -7.5% 0.5%
Operating Margin -12.0% 0.2%
EPS -2.25 1.69
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BIOA is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.